CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,935,000 | +35.1% | 17,116 | +19.6% | 0.00% | 0.0% |
| Q1 2017 | $1,432,000 | +7.4% | 14,309 | +15.4% | 0.00% | 0.0% |
| Q4 2016 | $1,333,000 | -1.0% | 12,403 | +14.7% | 0.00% | 0.0% |
| Q3 2016 | $1,346,000 | +17.9% | 10,818 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $1,142,000 | -5.1% | 10,749 | +2.3% | 0.00% | 0.0% |
| Q1 2016 | $1,203,000 | -11.6% | 10,512 | +9.9% | 0.00% | 0.0% |
| Q4 2015 | $1,361,000 | +72.9% | 9,562 | +9.0% | 0.00% | – |
| Q3 2015 | $787,000 | -27.1% | 8,773 | -6.5% | 0.00% | -100.0% |
| Q2 2015 | $1,079,000 | +34.2% | 9,378 | +11.3% | 0.00% | – |
| Q1 2015 | $804,000 | +70.3% | 8,424 | +19.8% | 0.00% | – |
| Q4 2014 | $472,000 | +63.9% | 7,030 | +31.3% | 0.00% | – |
| Q3 2014 | $288,000 | +39.8% | 5,356 | +15.6% | 0.00% | – |
| Q2 2014 | $206,000 | – | 4,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |